Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03835039 · ClinicalTrials.gov registry record
The Ability of NIRS to Predict Brain Injury in Hypoxic Ischemic Encephalopathy
A clinical trial, sponsored by Albany Medical College.
- Terminated
- Registry status
- 101
- Enrollment target
NCT03835039: Clinical Trial study, sponsored by Albany Medical College.
NCT03835039 is a clinical trial that was terminated before completion, run by Albany Medical College. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03835039 was terminated before completion, sponsored by Albany Medical College.
- TERMINATED
- Registry status
- 101 participants
- Enrollment target
Study Summary
A longitudinal study evaluating the predictive ability of near infrared spectroscopy to predict brain injury in infants with hypoxic ischemic encephalopathy. Data will be analyzed at two different time periods, at discharge and again at 2 years of age.
Primary Outcome
MRI studies will be reviewed and assessed for markers of HIE including damage to deep grey matter structures.
Interventions
- DEVICE NIRS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2019-01-03 |
| Est. Completion | 2022-01-01 |
Why NCT03835039 stopped before completion
NCT03835039 is an observational study that tracks outcomes without assigning an intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which NIRS is the first listed.
NCT03835039 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03835039 about?
NCT03835039 is a clinical study titled "The Ability of NIRS to Predict Brain Injury in Hypoxic Ischemic Encephalopathy". A longitudinal study evaluating the predictive ability of near infrared spectroscopy to predict brain injury in infants with hypoxic ischemic encephalopathy. Data will be analyzed at two different time periods, at discharge and again at 2 years of age.
What is the current status of trial NCT03835039?
This trial is currently terminated. The enrollment target is 101 participants. The study started on 2019-01-03. Estimated completion is 2022-01-01.
What interventions are being tested in trial NCT03835039?
The interventions under investigation include: NIRS (DEVICE).
Who is sponsoring clinical trial NCT03835039?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI